SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026683
Filing Date
2022-11-10
Accepted
2022-11-09 19:54:18
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20220930b_10q.htm   iXBRL 10-Q 1858486
2 EXHIBIT 31.1 ex_420026.htm EX-31.1 14343
3 EXHIBIT 31.2 ex_420027.htm EX-31.2 14438
4 EXHIBIT 32.1 ex_420028.htm EX-32.1 7088
5 EXHIBIT 32.2 ex_420029.htm EX-32.2 7361
  Complete submission text file 0001437749-22-026683.txt   8178223

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kmph-20220930.xsd EX-101.SCH 69639
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20220930_cal.xml EX-101.CAL 53732
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20220930_def.xml EX-101.DEF 444340
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20220930_lab.xml EX-101.LAB 421065
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20220930_pre.xml EX-101.PRE 469542
56 EXTRACTED XBRL INSTANCE DOCUMENT kmph20220930b_10q_htm.xml XML 1426711
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 221374469
SIC: 2834 Pharmaceutical Preparations